Back

Cytonics raises $4.8 million from 1,500 investments in latest financing

Verifying
  • Cytonics completed its latest financing campaign for its A2M-based biotechnology programs.
  • $4.8 million came from approximately 1,500 investments, including about 900 new investors.
  • Cytonics has raised $47 million and completed a first-in-human Phase 1 study of CYT-108.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.